APAC Infection Control Market

APAC Infection Control Market Size (2023 to 2028)

The Asia-Pacific infection control market is expected to grow at a CAGR of 14.44% CAGR from 2023 to 2028 and the market size is expected to be worth USD 22.32 billion by 2028 from USD 11.37 billion in 2023.

The growing number of people suffering from hospital-acquired infections is one of the primary factors driving the Asia-Pacific infection control market. In the Asia Pacific region, nearly 25% of patients admitted to the hospital for treatment procedures acquire infections. Patients with infections and healthcare workers prone to this virus reduced quality of life and sometimes death. Therefore, infection control and prevention play a significant role in decreasing these hospital-acquired infections. Increasing surgical procedures due to the increasing number of chronic diseases and accident is the primary reason for hospital-acquired infections. The spread of infections is mainly done through instruments used for the surgery for the patients.

Growing awareness regarding infection control is further boosting the infection control market in Asia-Pacific during the forecast period. In recent years, the spread of viruses or infections has been fast from one place to another or from one person to another. Most people are using disinfectants for infection control in every place. Infection prevention and control have become a significant task for people to live healthily. The government has increased programs on awareness about infection control devices and product usage to stay healthy.

The adoption of technological advancements also propels the infection control market growth in the Asia-Pacific region. The growing focus from the key market participants to manufacture infection control products and devices with technological developments such as sensors is anticipated to favor the growth rate of the APAC infection control market. In addition, the increasing number of product launches by market participants is expected to support market growth.

However, side effects of the infection control liquids, the high cost of the advanced products for infection control, lack of administrative support and resource constraints, and lack of awareness are the factors that restrain the infection control market growth in the Asia-Pacific. Furthermore, cleaning and sterilizing infection control instruments also hamper the market growth. In addition, long-term exposure to this infection control leads to some health diseases, such as breathing problems and lung damage also restrains the market growth.

This research report on the APAC infection control market has been segmented and sub-segmented into the following categories.

By Products and Services:

• Cleaning and disinfection products
• Sterilization products and services
• Endoscope reprocessing products
• Protective equipment
• Others

By End-User:

• Hospitals and clinics
• Medical device companies
• Pharmaceutical companies
• Life sciences companies
• Food Industry
• Others

By Country:

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Geographically, the Asia Pacific region accounted for a substantial share of the global infection control market in 2021. Being highly populated countries, India and China are playing a dominating role in this regional market. Due to the rapid spread of coronavirus infection in China, this infection control and prevention plays a significant role in reducing the virus. Additionally, the older population and the increase in chronic diseases such as diabetes, cancer, and heart diseases drive the infection control market forward in this region.

The Indian infection control market is anticipated to register a healthy CAGR during the forecast period. The increasing usage of single-use medical devices or instruments for infection control in India is one of the major factors accelerating the infection control market growth in India. In addition, the growing healthcare expenditure, increasing awareness among people regarding the hygienic environment, rising R&D activities around infection control, and increasing awareness among people regarding the significance of healthy lifestyles are expected to result in the Indian market growth.

The Japanese infection control market is estimated to showcase a steady growth rate during the forecast period. This is because the increasing number of measures taken by the Japanese government regarding infection control in healthcare settings drives Japan's infection control market growth. For instance, the government of Japan has made it mandatory for hospitals and public places to be sanitized well to reduce the risk of infection among the people.

KEY MARKET PLAYERS:

3M, Dr. Wiegert, Tuttnauer, STERIS Corporation, Advanced Sterilization Products, Ecolab, Belimed AG, Cantel Medical Corporation, Matachana Group, Shinva Medical Instrument Co., Ltd., Whiteley Corporation, Ruhof Corporation, Getinge Group, and MMM Group are some of the dominating companies operating in the APAC infection control market.